Our hypothesis is that the myocardial IL-33/ST2 pathway may be involved in the hemodynamic disarrangement in end-stage HF (ESHF) patients, candidates for LVAD implantation, and may be potentially responsible for their outcome. Here, IL33 is linked to hydrops fetalis.